HOME >> BIOLOGY >> NEWS
Variation in 3 genes influences risk of age-related macular degeneration

BOSTON (Aug. 29, 2006) -- Researchers in Boston have discovered a new common, noncoding variant in the Complement Factor H (CFH) gene that is associated with age-related macular degeneration (AMD), the leading cause of irreversible visual impairment and blindness among persons aged 60 and older. Their analyses, for the first time, combine this new variant with all previously reported variants to estimate individual risk of advanced AMD. They observed additive accumulation of risk from alleles at these three genes, including CFH on chromosome 1, complement factor B (BF) and complement component 2 (C2) genes on chromosome 6, and the LOC gene on chromosome 10. They estimate that genotypes related to five variants in these three genes explain about half the sibling risk of AMD in the study population. Results are published online in Nature Genetics.

The principal investigator, Johanna M. Seddon, M.D., Director of the Epidemiology Unit and Macular Degeneration specialist at the Massachusetts Eye and Ear Infirmary, and Associate Professor at Harvard Medical School, collaborated with co-authors from the Center for Human Genetic Research at Massachusetts General Hospital and the Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology. They studied 2,172 unrelated European-descended individuals 60 years of age or older, who were diagnosed on the basis of ocular examination and ocular photography (1,238 affected individuals and 934 controls). Affected individuals were defined as those having advanced AMD related to visual loss with either geographic atrophy (dry) or neovascular (wet) disease. Controls were individuals without AMD. The mean age was 74 for controls (54% female) and 78 years for affected individuals (55% female). Both Illumina and Sequenom methods were used to genotype about 1540 single nucleotide polymorphisms (snp's).

AMD is a "common disease" meaning that it is complex, i.e., ma
'"/>

Contact: Mary Leach
mary_leach@meei.harvard.edu
617-573-4170
Harvard Medical School
29-Aug-2006


Page: 1 2 3

Related biology news :

1. Variation in CHEK2 gene may triple breast cancer risk
2. Variation in bitter-taste receptor gene increases risk for alcoholism
3. Variation in HIVs ability to disable host defenses contributes to rapid evolution
4. Variation in immune response gene causes age-related macular degeneration when triggered
5. Variation in womens X chromosomes may explain differences among individuals, between sexes
6. Interaction of just 2 genes governs coloration patterns in mice
7. Gene regulation, not just genes, is what sets humans apart
8. Study finds gender differences in renal and other genes contributing to blood pressure
9. New databases put wings on search for bipolar risk genes
10. Research teams uncover risk genes for multiple sclerosis
11. Risk genes for multiple sclerosis uncovered

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... DIEGO (PRWEB) , ... September 20, 2018 , ... ... new 1.3.0 version of NovoExpress® software which supports the recently launched ... addition to NovoCyte® flow cytometer and NovoSampler® Pro products. , ...
(Date:9/15/2018)... YORK (PRWEB) , ... September 14, 2018 , ... ... of “Rare Diseases." This campaign will showcase the innovative work being done within ... as potential future therapies for those living with rare diseases. ...
(Date:9/7/2018)... ... 05, 2018 , ... Following up on the launch of ... IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed and delivered the ... provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ requirements for both ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... , ... September 06, 2018 , ... ... fatal neuromuscular disease, has been validated to be as effective as manual pathology. ... Dystrophin Staining in Frozen Muscle Biopsies,” was published in the Archives of Pathology ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis , an innovative ... completion of a $5.5 million funding round managed by Commenda Securities. Key investors ... and Ellipsis Ventures. , “Our investment in Nanovis is consistent with our mission ...
(Date:8/29/2018)... BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... optimization firm for the life sciences and healthcare industries, announces that Manu Vohra will ... on August 30th. , What: “How to Implement Box for GxP in 30 ...
(Date:8/21/2018)... , ... August 21, 2018 ... ... software company specializing in medical device compliance and commercialization, has just released ... platform. , Written and presented by Dr. Mario Kossmann, ESEP at the ...
Breaking Biology Technology:
Cached News: